u/Difficult_Hyena4821

Hi everyone,

I’m considering starting a position in CYDY and I’d like to do as much due diligence as possible before investing.

If you were starting from scratch today, what are the most important things I should read or verify first?

I’m especially interested in:

- The strongest bullish and bearish arguments.
- Key clinical trial data and upcoming catalysts.
- Regulatory history and any major risks.
- Financial situation (cash runway, dilution risk, etc.).
- Management and partnerships.
- Any old Reddit posts, SEC filings, or interviews that you consider “must-reads.”

I want to understand both the opportunities and the risks before making a decision.

Thanks in advance!

Hey guys,

Been digging into the GenFleet buyback news from a few days ago and tracking that June 30th PTCL study completion date that just passed. The timing on all of this is crazy. If the DD is right and the combined AML + PTCL peak revenue puts us in that $6.7B+ valuation range for an acquirer, a buyout is looking more and more like the end game here.

I'm still relatively new to biotech M&As though, so I had a quick question about how a bidding war actually plays out on the chart.

Hypothetically, if multiple big pharma companies start outbidding each other to acquire SLS, how does the share price and market cap behave on broker apps while those conditional offers are flying around?

Does the market cap on the app instantly jump to reflect the dollar amount of the highest pending bid, or does the price just fluctuate and trade close to the offer based on market volume until a deal is 100% signed and finalized?

Would love to hear from anyone who has held through similar biotech buyouts in the past.

Cheers!

Hey guys,

Been digging into the GenFleet buyback news from a few days ago and tracking that June 30th PTCL study completion date that just passed. The timing on all of this is crazy. If the DD is right and the combined AML + PTCL peak revenue puts us in that $6.7B+ valuation range for an acquirer, a buyout is looking more and more like the end game here.

I'm still relatively new to biotech M&As though, so I had a quick question about how a bidding war actually plays out on the chart.

Hypothetically, if multiple big pharma companies start outbidding each other to acquire SLS, how does the share price and market cap behave on broker apps while those conditional offers are flying around?

Does the market cap on the app instantly jump to reflect the dollar amount of the highest pending bid, or does the price just fluctuate and trade close to the offer based on market volume until a deal is 100% signed and finalized?

Would love to hear from anyone who has held through similar biotech buyouts in the past.

Cheers!